Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study is to evaluate the safety and effectiveness of rituximab in IgG4-RD.


Clinical Trial Description

This two-center trial will enroll at total of 30 patients with IgG4-RD. The two participating sites are the Massachusetts General Hospital (Boston, MA) and the Mayo Clinic (Rochester, MN). All patients will receive rituximab 1 gram intravenously times two doses, separated by approximately 15 days. The primary efficacy outcome - disease remission and successful completion of the glucocorticoid taper - will be assessed at six months. Patients will be followed on the protocol for an additional six months after measurement of the primary outcome. ;


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01584388
Study type Interventional
Source Massachusetts General Hospital
Contact
Status Completed
Phase Phase 1/Phase 2
Start date April 2012
Completion date January 2015

See also
  Status Clinical Trial Phase
Recruiting NCT03753815 - Diagnostic Yield of FNA Needle and FNB Needle for Autoimmune Pancreatitis N/A
Recruiting NCT02797665 - Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids N/A
Recruiting NCT04834505 - To Differentiate Focal Autoimmune Pancreatitis From Pancreatic Cancer by Endoscopic Ultrasound
Recruiting NCT04397731 - Prospective Study on the Role of Eus-fnb in the Diagnosis of Autoimmune Pancreatitis
Not yet recruiting NCT06358001 - EchoTip AcuCore Post-Market Clinical Study
Completed NCT05476978 - Artificial Intelligence in EUS for Diagnosing Pancreatic Solid Lesions
Recruiting NCT06369909 - Study on AI-assisted Multimodal Diagnosis System of Autoimmune Pancreatitis
Recruiting NCT01774513 - EUS-guided Procore-biopsy in Diagnosing Autoimmune Pancreatitis N/A
Completed NCT03241797 - Evaluation of EUS-guided FNA for Diagnosing Autoimmune Pancreatitis N/A
Completed NCT05171517 - Study on Microflora Characteristics of Pancreatic Solid Lesions Via Endoscopic Ultrasound-guided Fine Needle Aspiration/Biopsy
Withdrawn NCT01845467 - Efficacy of Secretin MRCP in the Diagnosis and Follow up of Auto Immune Pancreatitis
Completed NCT05565066 - A Real-world Comparison of FNB and FNA in IHC-required Lesions.
Completed NCT02705638 - Treatment of IgG4-Related Disease With Revlimid and Rituximab Phase 1
Withdrawn NCT02766842 - Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore) Phase 2
Completed NCT00588367 - CT Pancreas Perfusion N/A